Citation Tools
PDFAbstracts accepted for publication
Rheumatoid arthritis - prognosis, predictors and outcome
AB0188 Combination therapy with adalimumab plus methotrexate reduces circulating levels of pro-matrix matalloproteinases-1 and -3 independently of clinical disease activity in patients with rheumatoid arthritis
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- AB0188 Combination therapy with adalimumab plus methotrexate reduces circulating levels of pro-matrix matalloproteinases-1 and -3 independently of clinical disease activity in patients with rheumatoid arthritis